Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and the Safety of Flumatinib in CML-AP or CML-BP Patients [Phase 2]

View source ↗

Summary

A Phase II clinical trial assessing the efficacy and safety of Flumatinib in patients with chronic myeloid leukemia in accelerated or blast phase; sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Flumatinib (flumatinib)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Myelogenous Leukemia | Phase 2 | Status: UNKNOWN